Calculating gambling odds and lung ages for smokers

European Respiratory Journal

Volumn 35, Issue 4, 2010, Pages 776-780

  Hansen, J E ^a   Sun, X G ^a   Wasserman, K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic obstructive pulmonary disease; Lung age; Ratio of forced expiratory volume in 1 s to 6 s; Ratio of forced expiratory volume in 1 s to forced vital capacity; Spirometry

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; CIGARETTE SMOKING; ETHNICITY; EXPIRATORY RESERVE VOLUME; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOLOGICAL GAMBLING; PREDICTION; PRIORITY JOURNAL; SMOKING CESSATION; SPIROMETRY; VITAL CAPACITY;

ADULT; AGE DISTRIBUTION; AGED; FEMALE; GAMBLING; HUMANS; MALE; MIDDLE AGED; MOTIVATION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; SEX DISTRIBUTION; SMOKING; SMOKING CESSATION; SPIROMETRY; YOUNG ADULT;

EID: 77951200745     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00107709     Document Type: Article

References (37)

1. US Cancer Statistics Working Group. United States Cancer Statistics: 2004 Incidence and Mortality. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2007.
2. Centers for Disease Control and Prevention. Annual smoking-attributable mortality, years of potential life lost, and productivity losses - United States, 1997-2001. Morb Mort Wkly Rep 2005; 54: 625-628.
3. deVerdier MG. The big three concept: a way to tackle the health care crisis? Proc Am Thorac Soc 2008; 5: 800-805.
4. Rennard SI. Lessons from multidisciplinary cross-fertilization: chronic obstructive lung disease, lung cancer, and heart disease. Proc Am Thorac Soc 2008; 5: 865-868.
5. Global Stategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2008. Available from: www.goldcopd.org
6. Alamar B, Glantz S. Effect of increased social unacceptability of cigarette smoking on reduction in cigarette consumption. Am J Public Health 2006; 96: 359-363. (Pubitemid 44198655)
7. Vernick JS, Rutkow L, Teret SP. Public health benefits of recent litigation against the tobacco industry. JAMA 2007; 298: 86-89. (Pubitemid 47026773)
8. Carrozzi L, Pistelli F, Viegi G. Pharmacotherapy for smoking cessation. Ther Adv Respir Dis 2008; 2: 301-317.
9. Fagerstrom KG, Jiminez-Ruiz CA. Pharmacological treatments for tobacco dependence. Eur Respir Rev 2008; 17: 192-198.
10. Cornuz J, Willi C. Non-pharmacological smoking cessation interventions in clinical practice. Eur Respir Rev 2008; 17: 187-191.
11. Wilt TJ, Niewoehner D, Kim C, et al. Use of spirometry for case finding, diagnosis, and management of chronic obstructive lung disease (COPD). Evid Rep Technol Assess (Summ) 2005; 121: 1-7.
12. Boushey H, Enright P, Samet J. Spirometry for chronic obstructive pulmonary disease case finding in primary care? Am J Respir Crit Care Med 2005; 172: 1481-1482.
13. Kotz D, Wessling G, Hulbers MJH, et al. Efficacy of confronting snokers with airflow limitation for smoking cessation. Eur Respir J 2009; 33: 754-762.
14. Mannino DM. Should we be using statistics to define disease? Thorax 2008; 63: 1031-1032.
15. Pelligrino R, Viegi G, Brusasco V, et al. ATS/ERS task force: Standardization of lung function testing: interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
16. 1/FVC ratio below the fifth percentile, not <70%. Chest 2007; 131: 349-355.
17. Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63: 1046-1051.
18. Kazuhiro I, Barnes PJ. COPD as a disease of accelerated lung aging. Chest 2009; 135: 173-180.
19. Morris JF, Temple W. Spirometric "lung age" estimation for motivating smoking cessation. Prev Med 1985; 14: 655-662.
20. Parkes G, Greenhalgh T, Griffin M, et al. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ 2008; 336: 598-600. (Pubitemid 351439517)
21. US Department of Health and Human Services (DHHS) National Center for Health Statistics. Third national health and nutrition examination survey, 1998-1994: NHANES III raw spirometry data file. Hyattsville, MD: Centers for Disease Control and Prevention, 2001. www.cdc.gov/nchs/nhanes/nh3data.htm Date last updated: January 28, 2010.
22. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159: 179-187. (Pubitemid 29036522)
23. American Thoracic Society. Standardization of spirometry. 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
24. Hansen JE, Sun X-G, Wasserman K. Discriminating measures and normal values for expiratory obstruction. Chest 2006; 129: 369-377. (Pubitemid 43289857)
25. Hansen JE, Sun X-G, Wasserman K. Ethnic- and sex-free formula for detection of airway obstruction. Am J Respir Crit Care Med 2006; 174: 493-498. (Pubitemid 44330540)
26. Dixon WJ, Massey FJ Jr. Introduction to Statistical Analysis. 3rd Edn. New York, McGraw-Hill, 1969.
27. 1 in the COPD paradigm. COPD 2008; 5: 310-318.
28. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-1648. (Pubitemid 8124466)
29. Tashkin DP, Murray RP. Smoking cessation in chronic obstructive pulmonary disease. Respir Med 2009; 103: 963-974.
30. Lee TA, Bartle B, Weiss KB. Spirometry use in clinical practice following diagnosis of COPD. Chest 2006; 129: 1509-1515. (Pubitemid 43894979)
31. Wilson D, Adams R, Appleton S, et al. Difficulties identifying and targeting COPD and population-attributable risk of smoking for COPD. Chest 2005; 128: 2035-2042. (Pubitemid 41507538)
32. Brook RD, Franklin B, Cascio W, et al. Air pollution and cardiovascular disease: a statement for healthcare professionals from the expert panel on population and prevention science of the American Heart Association. Circulation 2004; 109: 2655-2671. (Pubitemid 38720571)
33. Miller KA, Siscovick DS, Sheppard L, et al. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med 2007; 356: 447-458. (Pubitemid 46193072)
34. Frostad A, Soyseth V, Haldorsen T, et al. Respiratory symptoms and long term cardiovascular mortality. Respir Med 2007; 101: 2289-2296. (Pubitemid 47495744)
35. Iwamoto H, Yokoyama A, Kitahara Y, et al. Airflow limitation in smokers is associated with subclinical atheroscelerosis. Am J Respir Crit Care Med 2009; 179: 35-40.
36. Cardiovascular disease statistics. www.americanheart.org/presenter.jhtml? identifier=4478 Date last accessed: January 29, 2010.
37. Schane RE, Glantz SA. Education on the dangers of passive smoking: a cessation strategy. Circulation 2008; 118: 1521-1523.